The remarkable advances in biotechnology and health sciences have led to a significant
production of data, such as high throughput genetic data and clinical information, generated …

Diabetes retinopathy (DR) is a leading cause of vision loss in middle‐aged and elderly
people globally. Early detection and prompt treatment allow prevention of diabetes‐related …

OBJECTIVE To estimate global and regional trends from 1990 to 2010 of the prevalence
and number of persons visually impaired specifically by diabetic retinopathy (DR), as a …

Diabetic retinopathy (DR) is a leading cause of vision-loss globally. Of an estimated 285
million people with diabetes mellitus worldwide, approximately one third have signs of DR …

OBJECTIVE To examine the global prevalence and major risk factors for diabetic retinopathy
(DR) and vision-threatening diabetic retinopathy (VTDR) among people with diabetes …

Obesity and related metabolic diseases show clear sex-related differences. The growing
burden of these diseases calls for better understanding of the age-and sex-related metabolic …

With increasing global prevalence of diabetes, diabetic retinopathy (DR) is set to be the
principle cause of vision impairment in many countries. DR affects a third of people with …

Diabetes mellitus is an extremely prevalent endocrine disease and a major global public
health concern. Diabetic complications, such as retinopathy, nephropathy, neuropathy and …

The management of diabetic retinopathy (DR) has evolved considerably over the past
decade, with the availability of new technologies (diagnostic and therapeutic). As such, the …

The alarming rise in diabetes prevalence is a global public health and economic problem.
Diabetic retinopathy is the most common complication of diabetes and the leading cause of …